Differences in Expression and Prognostic Values of p16(Ink4) and VEGF in Squamous and Adenocarcinoma of the Lung
Jusufovic Edin
Additional contact information
Jusufovic Edin: Health and Educational Institution “Dr. Mustafa Sehovic†, Centre for Specific and Non-Specific Lung Diseases; Tuzla, Bosnia and Herzegovina
Biomedical Journal of Scientific & Technical Research, 2023, vol. 51, issue 2, 42521-42530
Abstract:
Growing body of evidence suggests that molecular markers could have important prognostic value in non-small cell lung carcinoma (NSCLC) patients. Using targeted therapy based on these markers leads to improved outcomes in lung adenocarcinoma. However, progress of targeted therapy in squamous lung carcinoma is still modest. p16(ink4) protein acts as tumor suppressor.
Keywords: Journals on Medical Drug and Therapeutics; Journals on Emergency Medicine; Physical Medicine and Rehabilitation; Journals on Infectious Diseases Addiction Science and Clinical Pathology; Open Access Clinical and Medical Journal; Journals on Biomedical Science; List of Open Access Medical Journal; Journals on Biomedical Engineering; Open Access Medical Journal; Biomedical Science Articles; Journal of Scientific and Technical Research (search for similar items in EconPapers)
Date: 2023
References: Add references at CitEc
Citations:
Downloads: (external link)
https://biomedres.us/pdfs/BJSTR.MS.ID.008076.pdf (application/pdf)
https://biomedres.us/fulltexts/BJSTR.MS.ID.008076.php (text/html)
Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.
Export reference: BibTeX
RIS (EndNote, ProCite, RefMan)
HTML/Text
Persistent link: https://EconPapers.repec.org/RePEc:abf:journl:v:51:y:2023:i:2:p:42521-42530
DOI: 10.26717/BJSTR.2023.51.008076
Access Statistics for this article
Biomedical Journal of Scientific & Technical Research is currently edited by Robert Thomas
More articles in Biomedical Journal of Scientific & Technical Research from Biomedical Research Network+, LLC
Bibliographic data for series maintained by Angela Roy ().